Mobile App Risk is Business Risk.
Regulators are watching Enterprise mobile apps. Users demand transparency. Get instant visibility into privacy risks, AI data exposure, dangerous permissions and suspicious network connections across your entire enterprise app portfolio.
Search 2,000+ Enterprise Apps. Know Your Risk in Minutes.
Rejoyn™
Rejoyn™
Meet Rejoyn™, the first and only add-on prescription app for the treatment of major depressive disorder symptoms, also known as depression. Rejoyn is authorized by the FDA for adults age 22+ who want to add to their antidepressant medication. Over the course of 6 weeks, Rejoyn delivers proven brain-training exercises and short skills-based therapy lessons. Unlike wellness apps, Rejoyn was studied in a phase 3 clinical trial and is classified as a medical device. Rejoyn requires a prescription from a healthcare provider.
The brain-training exercises in Rejoyn were developed and studied by a team of psychologists, psychiatrists, and neuroscientists. In a clinical trial, adding Rejoyn to antidepressant medication reduced depression symptoms with zero side effects related to Rejoyn. The exercises and lessons in Rejoyn tap into the brain's natural ability to change, known as neuroplasticity. You can think of it like physical therapy, but for your brain. Using Rejoyn for less than 2 hours per week for 6 weeks is designed to change how the brain works, which can improve depression symptoms.
Rejoyn core functionality also includes reminders to help keep you on schedule. For example, if your treatment session is interrupted, you will be prompted to return to complete your exercise within 15 minutes so that you don’t lose your progress.
Interested in trying Rejoyn?
Rejoyn must be prescribed by a healthcare provider. Talk to your provider about Rejoyn or learn how you can consult with a provider online at www.rejoyn.com.
Already have a prescription?
Download the app to get started. Once Rejoyn is downloaded, the app will guide you through setting up your account.
For more information, visit www.rejoyn.com.
See Patient Instructions for Use at https://www.rejoyn.com/Patient-Instructions-for-Use.pdf.
INDICATION: Rejoyn is a prescription digital therapeutic for the treatment of Major Depressive Disorder (MDD) symptoms as an adjunct to clinician-managed outpatient care for adult patients with MDD age 22 years and older who are on antidepressant medication. It is intended to reduce MDD symptoms.
SAFETY INFORMATION: Rejoyn is not intended to be used as a standalone treatment. Rejoyn does not replace your current medication, including medication for treatment of MDD. You should continue your current treatment as directed by your healthcare provider.
Rejoyn cannot send alerts or warnings to your healthcare provider. If you feel that your depression symptoms are worsening or if you have feelings or thoughts of harming yourself or others, please contact your healthcare provider, dial 911, or go to the nearest emergency room immediately.
To review the developer’s Privacy Policy, visit http://www.rejoyn.com/app-privacy-policy-html.
© 2024 Otsuka Precision Health, Inc. All rights reserved.
September 2024 20US24EBC0073
Rejoyn™
Package ID
com.oph.prod.ct152.rejoyn
Version
3244
Developer
Otsuka Precision Health, Inc.
Category
Medical
Store Rank
83
App Store Link
View in Google PlayDeveloper Privacy Policy
Privacy PolicyObservations Summary:
Privacy Declarations Observations
NOT DETECTEDThis test did not detect a discrepancy, indicating all required declarations are disclosed.
- See Your App’s Risk Profile
Why Privacy Declarations Matter
Declarations matter because they provide transparency on how apps collect and use sensitive data. iOS requires Privacy Manifest declarations, while Android requires Data Safety disclosures and manifest permissions.
Sensitive Data Collection and Sharing Observations
NONE DETECTEDNone detected. Further analysis recommended.
- See Your App’s Risk Profile
Why Data Collection and Sharing Matters
If not managed properly private data can expose enterprises, customers, employees and partners to breach and compliance violations.
AI Observations
NONE DETECTEDNone detected. Further analysis recommended.
- See Your App’s Risk Profile
Why AI Matters
AI features can process sensitive data in unexpected ways, potentially exposing proprietary information or creating liability.
Network Connections Observations
NONE DETECTEDNone detected. Further analysis recommended.
- See Your App’s Risk Profile
Why Network Connections Matter
Uncontrolled communication with external servers by an employee-used app could expose sensitive business data to unauthorized third parties. This unauthorized access can lead to data breaches, regulatory non-compliance, and damage to your business's reputation and financial standing.
All trademarks, logos, and brand names are the property of their respective owners. All company, product, and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.
MARC App Directory